• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018 - Product Image Special Offer Sale Banner

Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018

  • Published: September 2013
  • Region: Global
  • 229 Pages
  • Markets and Markets
Special Offer Banner
25%
OFF
Offer ends 31st Aug 2014

FEATURED COMPANIES

  • Alafair Biosciences, Inc
  • Axogen, Inc
  • Baxter International, Inc
  • Biocontrol Medical
  • Cyberonics, Inc
  • Medtronic, Inc
  • MORE

'Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018'

The nerve repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The market is expected to witness a high growth in nerve grafting and neuromodulation segments, as they offer effective solutions for peripheral nerve repair and chronic pain, incontinence, heart failure, headache, depression, and epilepsy.

Moreover, there are certain devices in clinical trials for newer applications; for instance, deep brain stimulation for Alzheimer’s and depression, and vagus nerve stimulation for heart failure. Novel therapies (such as stem cell therapy) and emerging markets provide huge growth opportunities. However, the major challenges faced by the industry are donor site morbidity and inadequate nerve regenerationby conduits. The neuromodulation market is expected to reach READ MORE >

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Key Data Points From Secondary Sources
1.6.5 Assumptions

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increasing Incidence Of Peripheral Nerve Injuries & Neurological Disorders To Propel Market Growth
3.3.1.2 Technological Advancements In Nerve Repair To Boost The Market
3.3.1.3 Favorable Reimbursement Policies Encourage The Product Usage
3.3.1.4 Expanded Target Applications And New Indications Are Expected To Stimulate The Growth Of Neuromodulation Devices
3.3.2 Restraints
3.3.2.1 Lack Of Surgeons And Patient Awareness To Hamper The Growth
3.3.2.2 Lack Of Trained Professionals To Pose A Negative Impact On The Market Growth
3.3.3 Opportunities
3.3.3.1 Novel Therapies Such As Use Of Stem Cells
3.3.3.2 Emerging Markets
3.3.4 Challenges
3.3.4.1 Donor Site Morbidity
3.3.4.2 Inadequate Nerve Regeneration By Conduits
3.4 Regulations For Nerve Repair And Regeneration Products
3.4.1 Regulations For Humanitarian Use Devices (Hud)
3.4.2 Regulations For Electrically Powered Devices
3.5 Strategic Benchmarking
3.5.1 Agreement Of Alafair Biosciences With University Of Texas
3.5.2 Acquisition Of Synovis Life Technologies, Inc. By Baxter International, Inc.
3.5.3 Acquisition Of Intelect Medical, Inc. By Boston Scientific Corporation 47
3.5.4 Agreement Of Cyberonics, Inc. With Cerbomed, Gmbh
3.5.5 New Product Launch By Polyganics
3.6 Market Share Analysis
3.6.1 Neuromodulation Market
3.6.1.1 Global
3.6.1.2 North America
3.6.1.3 Europe
3.6.1.4 Asia
3.6.2 Peripheral Nerve Repair Market
3.6.2.1 Global
3.6.2.2 North America
3.6.2.3 Europe
3.6.2.4 Asia

4 Global Nerve Repair And Regeneration Market
4.1 Introduction
4.2 Regeneration Market, By Surgery
4.2.1 Direct Neurorrhaphy
4.2.1.1 Epineural Repair
4.2.1.2 Perineural Repair
4.2.1.3 Group Fascicular Repair
4.2.2 Nerve Grafting
4.2.2.1 Autografts
4.2.2.2 Allografts
4.2.2.3 Xenografts
4.2.3 Stem Cell Therapy
4.2.4 Neurostimulation/Neuromodulation Surgery
4.2.4.1 External Neurostimulation/Neuromodulation Surgery
4.2.4.2 Internal Neurostimulation/Neuromodulation Surgery
4.3 Regeneration Market, By Products
4.3.1 Nerve Repair By Biomaterials
4.3.1.1 Nerve Conduits
4.3.1.2 Nerve Protectors
4.3.1.3 Nerve Wraps
4.3.1.4 Nerve Connectors
4.3.2 Nerve Repair By Neurostimulation/ Neuromodulation
4.3.2.1 Internal Neurostimulation
4.3.2.1.1 Spinal Cord Stimulation
4.3.2.1.2 Deep Brain Stimulation
4.3.2.1.3 Sacral Nerve Stimulation
4.3.2.1.4 Vagus Nerve Stimulation
4.3.2.1.5 Gastric Electrical Stimulation
4.3.2.2 External Neurostimulation
4.3.2.2.1 Transcutaneous Electrical Nerve Stimulation
4.3.2.2.2 Transcranial Magnetic Stimulation

5 Geographic Analysis
5.1 Introduction
5.2 North America
5.3 Europe
5.4 Asia
5.5 Rest Of The World

6 Competitive Landscape
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Agreements, Partnerships, Collaborations & Joint Ventures
6.4 New Product Launch
6.5 Expansions
6.6 Approvals

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
7.1 Alafair Biosciences, Inc.
7.2 Axogen, Inc.
7.3 Baxter International, Inc.
7.4 Biocontrol Medical
7.5 Boston Scientific Corporation
7.6 Cyberonics, Inc.
7.7 Integra Lifesciences Holdings Corp.
7.8 Medtronic, Inc.
7.9 Orthomed S.A.S.
7.10 Polyganics
7.11 Salumedica
7.12 St. Jude Medical
7.13 Stryker Corporation
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

Appendix

List Of Tables (88 Tables)

Table 1 Global Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 2 Global Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 3 Global Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 4 Global Surgery Market Volume, By Geography, 2011 – 2018 (No. Of Surgeries)
Table 5 Global Direct Surgery Market Volume, By Type, 2011 - 2018 (No. Of Surgeries)
Table 6 Direct Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 7 Epineural Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 8 Perineural Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 9 Group Fascicular Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 10 Global Nerve Grafting Surgery Market Volume, By Type, 2011 – 2018 (No. Of Surgeries)
Table 11 Nerve Grafting Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 12 Autografts Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 13 Allografts Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 14 Xenografts Surgery Market Volume, By Geography, 2011 – 2018 (No. Of Surgeries)
Table 15 Stem Cell Therapy Market Volume, By Geography, 2011 – 2018 (No. Of Surgeries)
Table 16 Global Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Surgeries)
Table 17 Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 18 External Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 19 Internal Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 20 Global Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 21 Regeneration Products Market, By Geography, 2011 – 2018 ($Million)
Table 22 Biomaterials Market, By Geography, 2011 – 2018 ($Million)
Table 23 Biomaterials Market, By Products, 2011 - 2018 ($Million)
Table 24 Nerve Conduits Market, By Geography, 2011 - 2018 ($Million)
Table 25 Nerve Protectors Market, By Geography, 2011 - 2018 ($Million)
Table 26 Nerve Wraps Market, By Geography, 2011 - 2018 ($Million)
Table 27 Nerve Connector Market, By Geography, 2011 - 2018 ($Million)
Table 28 Global Neurostimulation Products Market, By Type, 2011 - 2018 ($Million)
Table 29 Global Neurostimulation Products Volume Market, By Type, 2011 - 2018 (No. Of Units)
Table 30 Neurostimulation Products Market, By Geography, 2011 - 2018 ($Million)
Table 31 Global Internal Neurostimulation Market Revenue, By Type, 2011 - 2018 ($Million)
Table 32 Global Internal Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Units)
Table 33 Internal Neurostimulation Market Revenue, By Geography, 2011 - 2018 ($Million)
Table 34 Internal Neurostimulation Market Volume, By Geography, 2011 - 2018 (No. Of Units)
Table 35 Spinal Cord Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 36 Deep Brain Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 37 Sacral Nerve Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 38 Vagus Nerve Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 39 Gastric Electrical Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 40 Global External Neurostimulation Nerve Repair & Regeneration Market, By Type, 2011 - 2018 ($Million)
Table 41 Global External Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Units)
Table 42 External Neurostimulation Market, By Geography, 2011 - 2018 ($Million)
Table 43 External Neurostimulation Market Volume, By Geography, 2011 - 2018 (No. Of Units)
Table 44 Transcutaneous Electrical Nerve Stimulation Market, By Geography, 2011 – 2018 ($Million)
Table 45 Transcranial Magnetic Stimulation Market, By Geography, 2011– 2018 ($Million)
Table 46 Regeneration Products Market Revenue, By Geography, 2011 - 2018 ($Million)
Table 47 Regeneration Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 48 North America: Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 49 North America: Nerve Repair & Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 50 North America: Direct Nerve Repair Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 51 North America: Nerve Graftingsurgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 52 North America: Xenografts Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 53 North America: Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 54 North America: Neurostimulation Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 55 North America: Internal Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 56 North America: External Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 57 Europe: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 58 Europe: Nerve Repair & Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 59 Europe: Direct Nerve Repair Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 60 Europe: Nerve Grafting Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 61 Europe: Xenografts Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 62 Europe: Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 63 Europe: Neurostimulation Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 64 Europe: Internal Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 65 Europe: External Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 66 Asia: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 67 Asia: Nerve Repair & Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 68 Asia: Direct Nerve Repair Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 69 Asia: Nerve Grafting Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 70 Asia: Xenografts Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 71 Asia: Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 72 Asia: Neurostimulation Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 73 Asia: Internal Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 74 Asia: External Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 75 ROW: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 76 ROW: Nerve Repair & Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 77 Row: Direct Nerve Repair Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 78 Row: Nerve Grafting Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 79 Row: Xenografts Nerve Repair & Regeneration Market, By Products, 2011 – 2018 ($Million)
Table 80 Row: Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 81 Row: Neurostimulation Surgery Market, By Volume, 2011 – 2018 (No. Of Surgeries)
Table 82 Row: Internal Neurostimulation Market, By Products, 2011 – 2018 ($Million)
Table 83 Row: External Neurostimulation Market,By Products, 2011 – 2018 ($Million)
Table 84 Mergers & Acquisitions (January 2011 – March 2013)
Table 85 Agreements, Partnerships, Collaborations, Contracts, & Joint Ventures (April 2011 – September 2012)
Table 86 New Product Launches (May 2011 – September 2012)
Table 87 Expansions (May 2012 – July 2012)
Table 88 Approvals (January 2011 – June 2013)

List Of Figures (54 Figures)

Figure 1 Market Crackdown & Data Triangulation Methodology For Peripheral Nerve Repair Products Market
Figure 2 Market Crackdown & Data Triangulation Methodology For Peripheral Nerve Repair Surgery Market
Figure 3 Market Crackdown & Data Triangulation Methodology For Neuromodulation Market
Figure 4 Market Forecasting Model
Figure 5 Research Output – 360o Validation
Figure 6 Regeneration Market, By Geography, 2011 - 2018 ($Million)
Figure 7 Regeneration Market Segmentation
Figure 8 Market Dynamics
Figure 9 Strategic Benchmarking: Product Expansion & Enhancement
Figure 10 Global Neuromodulation Products: Market Share Analysis, By Key Players, 2012
Figure 11 North America: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 12 Europe: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 13 Asia: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 14 Global Peripheral Nerve Repair & Regeneration Products: Market Share Analysis, By Key Players, 2012
Figure 15 North America: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 16 Europe: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 17 Asia: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 18 Number Of Peripheral Nerve Repair Surgeries, By Type, 2011 – 2018 (Thousands)
Figure 19 Direct Nerve Repair Surgeries, By Type, 2013
Figure 20 Nerve Grafting Surgeries, By Type, 2013
Figure 21 Number Of Neuromodulation Surgeries, 2013 (Thousands) 74
Figure 22 Neuromodulation Market, Value - Volume Comparison, By Type, 2013
Figure 23 Lifecycle Of Neuromodulation Products
Figure 24 Opportunity Matrix: Neuromodulation Products, 2013
Figure 25 Nerve Repair Biomaterials Market Geographic & Product Analysis, 2013 ($Million)
Figure 26 Global Nerve Repair And Regeneration Market, By Geography, 2013
Figure 27 Geographic Reach Vs Product Portfolio Analysis: Key Players
Figure 28 Key Growth Strategies In Nerve Repair & Regeneration Market, 2011 – 2013
Figure 29 Axogen, Inc.: Total Revenue And R&D Expenses, 2009 – 2012 ($Million)
Figure 30 Axogen: Swot Analysis
Figure 31 Baxter International, Inc.: Total Revenue And R&D Expenses, 2009 – 2012 ($Billion)
Figure 32 Baxter International, Inc.: Geographic Revenue Mix, 2012
Figure 33 Baxter International, Inc.:Business Revenue Mix, 2012
Figure 34 Boston Scientific Corporation: Total Revenue And R&D Expenses, 2009 – 2012 ($Billion)
Figure 35 Boston Scientific Corporation: Geographic Revenue Mix, 2012
Figure 36 Boston Scientific Corporation: Business Revenue Mix, 2012
Figure 37 Boston Scientific Corporation: Swot Analysis
Figure 38 Cyberonics, Inc.: Total Revenue And R&D Expenses, 2010 – 2013 ($Million)
Figure 39 Cyberonics, Inc.: Geographic Revenue Mix, 2013
Figure 40 Integra Lifesciences Holding Corp.: Total Revenue And R&D Expenses, 2009 – 2012 ($Million)
Figure 41 Integra Lifesciences Holding Corp.: Geographic Revenue Mix, 2012
Figure 42 Integra Lifesciences Holding Corp.: Business Revenue Mix, 2012
Figure 43 Medtronic, Inc.: Total Revenue And R&D Expenses, 2009 – 2012 ($Billion)
Figure 44 Medtronic, Inc.: Geographic Revenue Mix, 2012
Figure 45 Medtronic, Inc.:Business Revenue Mix, 2012
Figure 46 Medtronic: Swot Analysis
Figure 47 St. Jude Medical, Inc.: Total Revenue And R&D Expenses, 2009 – 2012 ($Billion)
Figure 48 St. Jude Medical, Inc.: Geographic Revenue Mix, 2012
Figure 49 St. Jude Medical, Inc.: Business Revenue Mix, 2012
Figure 50 St Jude Medical: Swot Analysis
Figure 51 Stryker Corporation: Total Revenue And R&D Expenses, 2009 – 2012 ($Billion)
Figure 52 Stryker Corporation: Geographic Revenue Mix, 2012
Figure 53 Stryker Corporation: Business Revenue Mix, 2012
Figure 54 Stryker Corporation: Swot Analysis

This report categorizes the market into the peripheral nerve repair segment and the neuromodulation segment. The peripheral nerve repair segment consists of direct nerve repair, nerve grafting, and stem cell therapy, while neuromodulation is divided into external and internal neuromodulation segments. The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rise in aging population (with multiple co-occurring disorders such as Alzheimer’s, Parkinson’s, chronic pain, and epilepsy), increasing incidence of peripheral nerve injuries, favorable reimbursement policies, and technological advancements.

The market is estimated based on surgery volume and products revenue. Based on surgeries, the market is classified into neuromodulation, direct nerve repair, nerve grafting, and stem cell therapy. Direct nerve repair is categorized into three types, namely, epineural, perineural, and group fascicular repair and nerve grafting is performed by using autografts, allografts, and xenografts. Neuromodulation is classified into internal stimulation and external stimulation. Internal stimulation is a minimally invasive technique which is further classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. External stimulation is classified into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation.

Based on products, the market is categorized into two segments, namely, biomaterials and neuromodulation. The biomaterials market is further segmented into nerve conduits, nerve wraps, nerve protectors, and nerve connectors. The market is driven by improved efficacy, enhanced functional recovery, and rising awareness among neurological surgeons towards biomaterials. Neuromodulation products include Deep Brain Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Gastric Electric Stimulators.

Neuromodulation in this market is expected to grow at the highest CAGR in the next five years. The large number of effective products (with expanded applications) from major players and about 25 neuromodulation products entering into clinical trials in the next two years are the major factors driving this market. Though the peripheral market is in its infant stage, it proves to be promising due to the technological advancements in nerve grafting, rising awareness in the patient population, and quick recovery.

North America is the dominant market, with around one-third of the share. The leading market share is due to the high prevalence of chronic disorders like epilepsy, Parkinson’s, Alzheimer’s, chronic pain, urine and fecal incontinence, and depression, along with rise in aging population and large number of U.S. based manufacturers.Key players in the neuromodulation segment in this region include Medtronic (U.S.), St. Jude Medical(U.S.), Boston Scientific Corporation(U.S.), and Cyberonics(U.S.), while the leading players in the peripheral nerve repair market include Integra LifeSciences Corporation(U.S.), Stryker Corporation(U.S.), and AxoGen, Inc.(U.S.).

- Alafair Biosciences, Inc
- Axogen, Inc
- Baxter International, Inc
- Biocontrol Medical
- Boston Scientific Corporation
- Cyberonics, Inc
- Integra Lifesciences Holdings Corp
- Medtronic, Inc
- Orthomed SAS
- Polyganics
- Salumedica
- St Jude Medical
- Stryker Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos